DH
Donald Hooker Keybanc Latest Price Targets & Analyst Ratings
# | Stock | Price | Price Target |
Upside Downside | Rating | Date | |
---|---|---|---|---|---|---|---|
1 |
1
Teladoc Health
TDOC
$1.38B
| $7.82 | $100 |
1,179%
upside
| Overweight | 3 years ago |
|
2 |
2
Charles River Laboratories
CRL
$8.07B
| $163.99 | $390 |
138%
upside
| Overweight | 3 years ago |
|
3 |
3
Quest Diagnostics
DGX
$20.5B
| $183.49 | $170 |
7%
downside
| Overweight | 3 years ago |
|
4 |
4
IQVIA
IQV
$31.9B
| $187.68 | $290 |
55%
upside
| Overweight | 3 years ago |
|
5 |
5
Phreesia
PHR
$1.68B
| $28.13 | $73 |
160%
upside
| Overweight | 4 years ago |
|
6 |
6
Recursion Pharmaceuticals
RXRX
$2.01B
| $4.61 | $36 |
681%
upside
| Overweight | 4 years ago |
|
7 |
7
Veeva Systems
VEEV
$44.7B
| $272.93 | $353 |
29%
upside
| Overweight | 4 years ago |
|
8 |
8
Maximus
MMS
$4.97B
| $88.25 | $84 |
5%
downside
| Overweight | 5 years ago |
|
9 |
9
Labcorp
LH
$23.2B
| $278.67 | $170 |
39%
downside
| Overweight | 5 years ago |
|